Effects of the DNA topoisomerase II inhibitor merbarone in male mouse meiotic divisions in vivo: Cell cycle arrest and induction of aneuploidy

Environmental and Molecular Mutagenesis

Volumn 29, Issue 1, 1997, Pages 16-27

  Kallio, Marko ^a   Lähdetie, Jaana ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Aneuploidy; Cell cycle arrest; CREST; Merbarone; Micronuclei; Spermatogenesis

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; MERBARONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE; CENTROMERE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEIOSIS; MICRONUCLEUS TEST; MOUSE; NONHUMAN; POLYPLOIDY; SPERMATOCYTE;

ANEUPLOIDY; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CREST SYNDROME; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; ETOPOSIDE; IMMUNOHISTOCHEMISTRY; KINETOCHORES; MALE; MEIOSIS; MICE; MICE, INBRED BALB C; MICRONUCLEUS TESTS; MITOSIS; SEMINIFEROUS TUBULES; SPERMATIDS; SPERMATOZOA; STAINING AND LABELING; THIOBARBITURATES;

ANIMALIA;

EID: 1842328032     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1997)29:1<16::AID-EM3>3.0.CO;2-B     Document Type: Article

References (42)

1. Adachi Y, Luke M, and Laemmli UK (1991): Chromosome assembly in vitro: topoisomerase II is required for condensation. Cell 64:137-148.
2. Anderson RD, Berger NA (1994): Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutat Res 309:109-142.
3. Beck WT, Kim R, Chen M (1994): Novel inhibitors of DNA topoisomerase II in drug-resistant tumor cells. Cancer Chemother Pharmacol 34 suppl:14-18.
4. Brewer AD, Minatelli JA., Plowman J, Paoull KD, Narayanan VL (1985): 5-(N-phenylcarboxamido)-2-thiobarbituric acid (NSC-336628), a novel potential antitumor agent. Biochem Pharmacol 34:2047-2050.
5. Chen GL, Yang L, Rowe TC, Halligan BD, Tewey KM, Liu LF (1984): Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259:13560-13566.
6. Chen M, Beck WT (1993): Teniposide-resistant CEM cells, which express mutant DNA topoisomerase II, when treated with non-complex-stabilizing inhibitors of the enzyme, display no cross-resistance and reveal aberrant functions of the mutant enzyme. Cancer Res 53:5946-5953.
7. 2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26. Cancer Res 55:1509-1516.
8. Clarke DJ, Johnson RT, Downes CS (1993): Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. J Cell Sci 105:563-569.
9. Clermont Y, Harvey SC (1965): Duration of the cycle of the seminiferous epithelium of normal and hypophysectomized and hypophysectomized-hormone treated albino rats. Endocrinology 76:80-89.
10. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda CA, Raskind WH, Reid BJ (1995): A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
11. Downes CS, Mullinger AM, Johnson RT (1991): Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis. Proc Natl Acad Sci USA 88:8895-8899.
12. 2 cycle checkpoint in mammalian cells. Nature 372:467-470.
13. Drake FH, Hofmann GA, Mong SM, Bartus JO, Hertzberg RP, Johnson RK, Mattern MR, Mirabelli CK (1989a): In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. Cancer Res 49:2578-2583.
14. Drake FH, Hofmann GA, Bartus HF, Mattern, MR, Crooke ST, Mirabelli CK (1989b): Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry 28:8154-8160.
15. Gorbsky GJ (1994): Cell cycle progression and chromosome separation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (razoxane). Cancer Res 54:1042-1048.
16. Gorbsky GJ, Ricketts WA (1993): Differential expression of a phosphoepitope at the kinetochores of moving chromosomes. J Cell Biol 122:1311-1321.
17. Haldane A, Holdaway KM, Finlay GJ, Baguley BC (1993): Cytokinetic differences in the action of N-[2-(dimethylamino)-ethyl]acridine-4-carboxamide as compared with that of amsacrine and doxorubicin. Cancer Chemother Pharmacol 32:463-470.
18. Heck MM, Hittelman WN, Earnshaw WC (1988): Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 85:1086-1090.
19. Henriksén K, Kulmala J, Toppari J, Mehrotra K, Parvinen M (1996): Stage-specific apoptosis in the rat seminiferous epithelium: Quantification of irradiation effects. J Androl, in press.
20. Hirano T, Mitchison TJ (1993): Topoisomerase II does not play a scaffolding role in the organization of mitotic chromosomes assembled in Xenopus egg extracts. J Cell Biol 120:601-612.
21. Jeney A, Lapis K, Divald A, Kopper L, Nagy P, Kovalsky I, Timar F (1987): The effects of merbarone on the synthesis of biopolymers in P388 lymphoma cells. Proc Am Assoc Cancer Res 28:304.
22. Kallio M, Lähdetie J (1993): Analysis of micronuclei induced in mouse early spermatids by mitomycin C, vinblastine sulfate or etoposide using fluorescence in situ hybridization. Mutagenesis 8:561-567.
23. Kallio M, Lähdetie J (1996): Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male mouse meiosis in vivo by the topoisomerase II inhibitor etoposide. Mutagenesis 11:435-143.
24. Kallio M, Sjöblom T, Löhdetie J (1995) Effect of vinblastine and colchicine on male rat meiosis in vivo: Disturbances of spindle dynamics causing micronuclei and metaphase arrest. Environ Mol Mutagen 25:106-117.
25. Li X, Nicklas RB (1995): Mitotic forces control a cell-cycle checkpoint. Nature 373:630-632.
26. Long BH, Musial ST, Brattain MG (1985): Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Cancer Res 45:3106-3112.
27. Mailhes JB, Marchetti F, Phillips GL Jr, Barnhill, DR (1994): Preferential pericentric lesions and aneuploidy induced in mouse oocytes by the topoisomerase II inhibitor etoposide. Teratogen Carcinogen Mutagen 14:39-51.
28. Murray WA (1992): Creative blocks: Cell-cycle checkpoints and feedback controls. Nature 359:599-604.
29. Nicklas RB, Ward SC, Gorbsky GJ (1995): Kinetochore chemistry is sensitive to tension and may link mitotic forces to a cell cycle checkpoint. J Cell Biol 130:929-939.
30. Oakberg EF (1956): Duration of spermatogenesis in the mouse and timing of stages of the cycle of the seminiferous epithelium. Am J Anat 99:507-516.
31. Parvinen M, Toppari J, Lähdetie J (1993): Transillumination phase contrast microscopic techniques for evaluation of male germ cell toxicity and mutagenicity. Methods Toxicol 3:142-165.
32. 2 phase and mitotic BHK cells. J Cell Biol 111:1753-1762.
33. Russell LD, Ettlin RA, SinhaHikim AP, Clegg ED (1990): Staging for the mouse. In "Histological and Histopathological Evaluation of the Testis." Clearwater, FL: Cache River Press, pp. 119-162.
34. Sørensen BS, Sindling J, Andersen AH, Alsner J, Jensen PB, Westergaard O (1992): Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events. J Mol Biol 228:778-786.
35. Spiridonidis CA, Chatterjee S, Petzold SJ, Berger NA (1989): Topoisomerase II-dependent and -independent mechanisms of etoposide resistance in Chinese hamster cell lines. Cancer Res 49:644-650.
36. Stewart N, Hicks GG, Paraskevas F, Mowat M (1995): Evidence for a second cell cycle block at G2/M by p53. Oncogene 10:109-115.
37. Sumner AT (1972): A simple technique for demonstrating centromeric heterochromatin. Exp Cell Res 75:304-306.
38. Sumner AT (1995): Inhibitors of topoisomerase II delay progression through mitosis and induce a doubling of the DNA content in CHO cells. Exp Cell Res 217:440-447.
39. Van Hummelen P, Deleener A, Vanparys Ph, Kirsch-Volders M (1992): Discrimination of aneuploidogens from clastogens by C-banding, DNA and area measurements of micronuclei from mouse bone marrow. Mutat Res 271:13-28.
40. Woessner RD, Mattern MR, Mirabelli CK, Johnson RK, Drake FH (1991): Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ 2:209-214.
41. Wolf KW (1994): How meiotic cells deal with nonexchange chromosomes. Bioessays 2:107-114.
42. Yamamoto KI, Kikuchi Y (1980): A comparison of diameters of micronuclei induced by clastogens and by spindle poisons. Mutat Res 71:127-131.